| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 31,093 | 14,912 | 6,852 | 19,215 | | Cost of Revenue | 20,592 | 10,290 | 6,391 | 13,045 | | | Gross Profit | 10,501 | 4,622 | 461 | 6,170 | | | Operating Expenses | | Research Development | 16,350 | 15,802 | 11,434 | 12,715 | | Selling General and Administrative | 8,837 | 7,421 | 3,626 | 8,465 | | Non Recurring | 1,508 | 705 | 1,473 | 761 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (16,194) | (19,306) | (16,072) | (15,771) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (533) | (806) | 1,287 | 2,057 | | Earnings Before Interest And Taxes | (16,727) | (20,112) | (14,785) | (13,714) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (16,727) | (20,112) | (14,785) | (13,714) | | Income Tax Expense | 429 | 963 | 1,819 | 870 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (17,156) | (21,075) | (16,604) | (14,584) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (17,156) | (21,075) | (16,604) | (14,584) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($17,156) | ($21,075) | ($16,604) | ($14,584) |
|
0.31% Nasdaq 
0.05%
Income Statement
